Decoy Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
DCOY chart
What traders are saying about $DCOY
Latest postsDecoy Therapeutics Inc. news
- Decoy Therapeutics Inc. Estimates – NASDAQ:DCOY
TradingView ·
- The Small Cap Showcase Highlights 8 Public Companies at Their Investor Conference Today
Yahoo Finance ·
- Decoy Therapeutics to Present at The Small Cap Showcase
Yahoo Finance ·
- Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program
Yahoo Finance ·
- Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release
Yahoo Finance ·
- /C O R R E C T I O N -- Decoy Therapeutics, Inc/
Yahoo Finance ·
- Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules
Yahoo Finance ·
- Decoy Therapeutics Exploring Pan-Filovirus Program via FDA Animal Rule Pathway and Non-Dilutive Funding
Yahoo Finance ·
- Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference
Yahoo Finance ·
- Decoy Therapeutics Expands Intellectual Property Portfolio Covering Designable Multi-Antivirals and the IMP³ACT™ Platform
Yahoo Finance ·
- Decoy Therapeutics Announces Breakthrough In Vitro Activity Against Ebola Zaire, Expanding D-MAV™ Platform into High Consequence Global Health Threats
Yahoo Finance ·
- Decoy Therapeutics Stockholders Elect Patricia Gauthier to Board of Directors
Yahoo Finance ·
Decoy Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $0 |
| Net income | $12.5M | $5.6M | $12.5M | -$31.6M |
| Diluted EPS | $-129.10 | $-69.54 | $-30.74 | $-14.88 |
| Total assets (year end) | $11.1M | $3.0M | $6.6M | $14.7M |
| Cash and equivalents (year end) | $10.7M | $2.4M | $5.9M | $12.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Decoy Therapeutics Inc.
- Ticker
- DCOY (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1615219
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
Frequently asked questions
What exchange is Decoy Therapeutics Inc. listed on?
Decoy Therapeutics Inc. trades on the Nasdaq under the ticker symbol DCOY.
What industry is Decoy Therapeutics Inc. in?
Decoy Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Decoy Therapeutics Inc. headquartered?
Decoy Therapeutics Inc.'s business address on file with the SEC is in Houston, TX.
When does Decoy Therapeutics Inc.'s fiscal year end?
Decoy Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Decoy Therapeutics Inc. report?
Decoy Therapeutics Inc. reported $0 in revenue for calendar year 2022, according to its SEC filings.